Veterinary Medicines

ALFAXAN 10 mg/ml solution for injection for dogs and cats

Authorised
  • Alfaxalone
Download as PDF

Product identification

Medicine name:
ALFAXAN 10 mg/ml solution for injection for dogs and cats
Alfaxan 10 mg/ml injektioneste, liuos
Active substance:
  • Alfaxalone
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Alfaxalone
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • Cardboard box with one glass vial of 10 ml with a bromobutyl rubber stopper and aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Jurox (Ireland) Limited
  • Zoetis Belgium
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 32436
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0590/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Hungary
  • Italy
  • Netherlands
  • Norway
  • Portugal
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Finnish (PDF)
Published on: 18/06/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 18/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."